+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Market - Global Forecast 2026-2032- Product Image
Gene Editing Market - Global Forecast 2026-2032- Product Image
Sale

Gene Editing Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6017517
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Editing Market is projected to reach USD 5.99 Billion in 2026. It is expected to continue growing at a CAGR of 14.96%, reaching USD 13.88 Billion by 2032.

Gene Editing: Executive Overview

Gene editing encompasses technologies that alter DNA at targeted locations for research, therapeutic, agricultural, and industrial applications. The field is progressing from experimental tools toward more controlled, clinically oriented platforms, with progress shaped by editing precision, delivery, safety, manufacturing, regulation, and public acceptance.

How Gene Editing Is Reshaping Research and Healthcare

The landscape is shifting from proof-of-concept experimentation toward applications that require reproducible editing, durable outcomes, and clearly defined risk controls. Base editing and prime editing are expanding the range of possible genetic changes, while improved delivery systems are addressing a central barrier to editing tissues beyond accessible cell types. Translational progress increasingly depends on integrated capabilities spanning molecular design, biomarker development, quality control, clinical operations, and long-term monitoring.

Artificial Intelligence Accelerates the Gene-Editing Workflow

Artificial intelligence is being applied across target identification, guide-RNA design, protein engineering, off-target prediction, delivery optimization, image analysis, and patient selection. Its cumulative effect is to help researchers evaluate larger design spaces and prioritize experiments more efficiently, but outputs remain dependent on high-quality biological data and experimental validation. Governance, model interpretability, data provenance, and controls against unintended edits remain essential as AI becomes embedded in discovery and development workflows.

Regional Dynamics Across Gene Editing

North America combines strong biomedical research capacity, venture activity, clinical infrastructure, and established regulatory pathways, while Latin America is building capability through research institutions, agricultural applications, and public-sector partnerships. Europe emphasizes rigorous oversight, cross-border research coordination, and translational medicine. The Middle East is developing biotechnology capacity through national innovation programs and specialized healthcare investment, and Africa is prioritizing applications linked to infectious disease, agriculture, and locally relevant health needs. Asia-Pacific is a major center for research, manufacturing, clinical development, and agricultural innovation, with policies and capabilities varying substantially across economies.

Strategic Patterns Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members show varied readiness, with opportunities in agriculture, diagnostics, and biomedical research alongside differences in regulation and infrastructure. BRICS countries bring substantial scientific, agricultural, and healthcare diversity, but collaboration is influenced by distinct national policies and technology-access conditions. The European Union benefits from coordinated research mechanisms while maintaining demanding ethical and regulatory requirements. G7 economies generally combine advanced research systems with mature governance and commercialization capabilities. GCC countries are strengthening biomedical infrastructure and talent development, while NATO members contribute extensive research, defense-health, and biosecurity capabilities, although the group is not a single regulatory or commercial market.

Country-Level Priorities in Gene Editing

Australia is advancing biomedical research and agricultural applications through strong public institutions. Brazil is especially relevant to agricultural biotechnology and health research, while Canada combines genomics expertise with translational research capacity. China is investing broadly across therapeutic, agricultural, and platform development, and France and Germany contribute major academic, industrial, and regulatory capabilities within Europe. India is expanding research, manufacturing, and healthcare applications; Italy and Spain are strengthening translational and clinical ecosystems. Japan and South Korea are developing advanced regenerative-medicine and biotechnology capabilities. Mexico is building capacity through research and agricultural applications. Russia maintains scientific capabilities but faces constraints related to international collaboration and access. The United Kingdom and United States remain important centers for discovery, clinical translation, regulation, and investment, with continued attention to safety, ethics, and equitable access.

Actions for Leaders Navigating Gene-Editing Complexity

Industry leaders should prioritize platforms with measurable precision, reliable delivery, and defensible safety evidence rather than focusing solely on editing efficiency. They should establish cross-functional governance covering ethics, regulatory strategy, cybersecurity, data quality, and long-term patient monitoring. Partnerships with hospitals, academic laboratories, agricultural organizations, and manufacturing specialists can close capability gaps, while modular development plans can reduce technical and regulatory risk. Leaders should also prepare region-specific access strategies, invest in workforce development, and use AI under documented validation and human oversight.

Research Methodology for the Executive Summary

This summary uses a qualitative synthesis of established gene-editing concepts, technological developments, translational requirements, regulatory considerations, and the specified regional, group, and country frameworks. Insights are organized around technology, applications, enabling infrastructure, governance, and adoption conditions. No market estimates, market shares, forecasts, or company-specific claims are included; conclusions should be validated against current peer-reviewed literature, regulatory publications, clinical-trial records, and national policy sources before operational decisions are made.

Conclusion: Building Responsible Gene-Editing Capability

Gene editing is moving toward broader real-world use, but progress will depend on more than technical sophistication. Precision, delivery, safety evidence, scalable manufacturing, regulatory clarity, public trust, and equitable access must advance together. Organizations that combine disciplined science with responsible governance, regional awareness, and carefully validated AI capabilities will be better positioned to translate gene-editing innovation into durable societal and clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gene Editing Market, by Offering
7.1. Introduction
7.2. Reagents & Consumables
7.2.1. Guide RNAs
7.2.2. Nucleases & Editors
7.2.3. Donor Templates
7.2.4. Assay Kits
7.3. Instruments & Devices
7.3.1. Electroporation Systems
7.3.2. Microinjection Systems
7.3.3. Automated Cell Processors
7.4. Software & Informatics
7.4.1. Off-Target Analysis Software
7.4.2. Data Management Platforms
7.5. Services
7.5.1. Cell-Line Engineering Services
7.5.2. Screening & Validation Services
7.5.3. Preclinical Editing Services
8. Gene Editing Market, by Technology
8.1. Introduction
8.2. Programmable Nuclease Systems
8.2.1. CRISPR-Cas Nucleases
8.2.1.1. Cas9 Systems
8.2.1.2. Cas12 Systems
8.2.1.3. Cas13 Systems
8.2.1.4. Cas3 Systems
8.2.2. TALENs
8.2.3. ZFNs
8.3. Base Editing
8.4. Prime Editing
9. Gene Editing Market, by Delivery System
9.1. Introduction
9.2. Viral Vectors
9.3. Nonviral Carriers
9.4. Hybrid Systems
10. Gene Editing Market, by Target System
10.1. Introduction
10.2. Human Cells
10.2.1. Hematopoietic Stem Cells
10.2.2. Primary Somatic Cells
10.3. Non-Human Animal Systems
10.3.1. Rodent Models
10.3.2. Livestock
10.4. Plant Systems
10.4.1. Row Crops
10.4.2. Specialty Crops
10.4.3. Plant Cell Cultures
10.5. Microbial Systems
10.5.1. Bacteria
10.5.2. Yeast
10.5.3. Filamentous Fungi
10.5.4. Microalgae
10.6. Viral Genomes
10.7. Cell-Free Systems
11. Gene Editing Market, by Editing Environment
11.1. Introduction
11.2. In Vivo Editing
11.3. Ex Vivo Editing
12. Gene Editing Market, by Application
12.1. Introduction
12.2. Basic Research
12.3. Therapeutics & Vaccines
12.4. Diagnostics
12.5. Agricultural Biotechnology
12.6. Biomanufacturing
12.7. Industrial & Environmental Biotechnology
13. Gene Editing Market, by End User
13.1. Introduction
13.2. Academic & Government Institutes
13.3. Biopharma Companies
13.4. Contract Research Organizations (CROs)
13.5. Diagnostic Laboratories
13.6. Agriculture & Food Companies
14. Gene Editing Market, by Region
14.1. Introduction
14.2. North America
14.3. Europe
14.4. Asia-Pacific
14.5. Latin America
14.6. Africa
14.7. Middle East
15. Gene Editing Market, by Group
15.1. Introduction
15.2. NATO
15.3. G7
15.4. European Union
15.5. BRICS
15.6. ASEAN
15.7. GCC
16. Gene Editing Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Germany
16.5. United Kingdom
16.6. Japan
16.7. Canada
16.8. Mexico
16.9. India
16.10. Brazil
16.11. France
16.12. South Korea
16.13. Italy
16.14. Australia
16.15. Spain
16.16. Russia
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gene Editing Market, Years Considered for the Study
FIGURE 2. Global Gene Editing Market, Research Design
FIGURE 3. Global Gene Editing Market, Research Framework
FIGURE 4. Global Gene Editing Market, Data Triangulation
FIGURE 5. Global Gene Editing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gene Editing Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global Gene Editing Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gene Editing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Gene Editing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gene Editing Market Size, by Delivery System, 2025 vs 2032 (%)
FIGURE 11. Global Gene Editing Market Size, by Delivery System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gene Editing Market Size, by Target System, 2025 vs 2032 (%)
FIGURE 13. Global Gene Editing Market Size, by Target System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gene Editing Market Size, by Editing Environment, 2025 vs 2032 (%)
FIGURE 15. Global Gene Editing Market Size, by Editing Environment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gene Editing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Gene Editing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gene Editing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Gene Editing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Gene Editing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Gene Editing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Gene Editing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Gene Editing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Gene Editing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Gene Editing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gene Editing Market Segmentation & Coverage
TABLE 2. Global Gene Editing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Guide RNAs Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Guide RNAs Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Guide RNAs Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nucleases & Editors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nucleases & Editors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nucleases & Editors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Donor Templates Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Donor Templates Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Donor Templates Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Instruments & Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Instruments & Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Instruments & Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Electroporation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Electroporation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Electroporation Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Microinjection Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Microinjection Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Microinjection Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Automated Cell Processors Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Automated Cell Processors Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Automated Cell Processors Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Software & Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Software & Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Software & Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Off-Target Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Off-Target Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Off-Target Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Data Management Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Data Management Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Data Management Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cell-Line Engineering Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cell-Line Engineering Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cell-Line Engineering Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Screening & Validation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Screening & Validation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Screening & Validation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Preclinical Editing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Preclinical Editing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Preclinical Editing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 53. Global Programmable Nuclease Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Programmable Nuclease Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Programmable Nuclease Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global CRISPR-Cas Nucleases Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global CRISPR-Cas Nucleases Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global CRISPR-Cas Nucleases Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Cas9 Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Cas9 Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Cas9 Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Cas12 Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Cas12 Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Cas12 Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Cas13 Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Cas13 Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Cas13 Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cas3 Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cas3 Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cas3 Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global TALENs Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global TALENs Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global TALENs Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global ZFNs Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global ZFNs Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global ZFNs Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Base Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Base Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Base Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Prime Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Prime Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Prime Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 84. Global Viral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Viral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Viral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Nonviral Carriers Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Nonviral Carriers Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Nonviral Carriers Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hybrid Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hybrid Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hybrid Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 94. Global Human Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Human Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Human Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Hematopoietic Stem Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Hematopoietic Stem Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Hematopoietic Stem Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Primary Somatic Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Primary Somatic Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Primary Somatic Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Non-Human Animal Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Non-Human Animal Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Non-Human Animal Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Rodent Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Rodent Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Rodent Models Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Plant Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Plant Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Plant Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Row Crops Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Row Crops Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Row Crops Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Specialty Crops Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Specialty Crops Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Specialty Crops Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Plant Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Plant Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Plant Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Microbial Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Microbial Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Microbial Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Yeast Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Yeast Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Yeast Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Filamentous Fungi Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Filamentous Fungi Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Filamentous Fungi Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Microalgae Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Microalgae Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Microalgae Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Viral Genomes Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Viral Genomes Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Viral Genomes Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Cell-Free Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Cell-Free Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Cell-Free Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 146. Global In Vivo Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global In Vivo Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global In Vivo Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Ex Vivo Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Ex Vivo Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Ex Vivo Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Global Basic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Basic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Basic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Therapeutics & Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Therapeutics & Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Therapeutics & Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Agricultural Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Agricultural Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Agricultural Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Biomanufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Industrial & Environmental Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Industrial & Environmental Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Industrial & Environmental Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Global Academic & Government Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Academic & Government Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Academic & Government Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Biopharma Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Biopharma Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Biopharma Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Contract Research Organizations (CROs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Contract Research Organizations (CROs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Contract Research Organizations (CROs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Agriculture & Food Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Agriculture & Food Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Agriculture & Food Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. North America Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. North America Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 190. North America Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 191. North America Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 192. North America Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 193. North America Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 194. North America Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. North America Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 196. North America Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 197. North America Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 198. North America Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 199. North America Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 200. North America Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 201. North America Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 202. North America Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 203. North America Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 204. North America Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. North America Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Europe Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Europe Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 208. Europe Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 209. Europe Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 210. Europe Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 211. Europe Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 212. Europe Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. Europe Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 214. Europe Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 215. Europe Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 216. Europe Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 217. Europe Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 218. Europe Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 219. Europe Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 220. Europe Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 221. Europe Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 222. Europe Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. Europe Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 229. Asia-Pacific Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 233. Asia-Pacific Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 234. Asia-Pacific Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 235. Asia-Pacific Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 236. Asia-Pacific Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Latin America Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Latin America Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 244. Latin America Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 245. Latin America Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 246. Latin America Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 247. Latin America Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. Latin America Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Latin America Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 250. Latin America Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 251. Latin America Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 252. Latin America Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 253. Latin America Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 254. Latin America Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 255. Latin America Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 256. Latin America Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 257. Latin America Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 258. Latin America Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Latin America Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Africa Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 261. Africa Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 262. Africa Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 263. Africa Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 264. Africa Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 265. Africa Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 266. Africa Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. Africa Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 268. Africa Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 269. Africa Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 270. Africa Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 271. Africa Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 272. Africa Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 273. Africa Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 274. Africa Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 275. Africa Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 276. Africa Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Africa Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Middle East Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 279. Middle East Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 280. Middle East Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 281. Middle East Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 282. Middle East Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 283. Middle East Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 284. Middle East Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 285. Middle East Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 286. Middle East Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 287. Middle East Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 288. Middle East Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 289. Middle East Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 290. Middle East Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 291. Middle East Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 292. Middle East Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 293. Middle East Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 294. Middle East Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. Middle East Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Global Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. NATO Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 298. NATO Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 299. NATO Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 300. NATO Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 301. NATO Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 302. NATO Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 303. NATO Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. NATO Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 305. NATO Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 306. NATO Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 307. NATO Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 308. NATO Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 309. NATO Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 310. NATO Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 311. NATO Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 312. NATO Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 313. NATO Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. NATO Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. G7 Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. G7 Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 317. G7 Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 318. G7 Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 319. G7 Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 320. G7 Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 321. G7 Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 322. G7 Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 323. G7 Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 324. G7 Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 325. G7 Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 326. G7 Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 327. G7 Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 328. G7 Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 329. G7 Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 330. G7 Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 331. G7 Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. G7 Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. European Union Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. European Union Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 335. European Union Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 336. European Union Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 337. European Union Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 338. European Union Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 339. European Union Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 340. European Union Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 341. European Union Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 342. European Union Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 343. European Union Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 344. European Union Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 345. European Union Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 346. European Union Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 347. European Union Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 348. European Union Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 349. European Union Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. European Union Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 351. BRICS Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 352. BRICS Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 353. BRICS Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 354. BRICS Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 355. BRICS Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 356. BRICS Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 357. BRICS Gene Editing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 358. BRICS Gene Editing Market Size, by Programmable Nuclease Systems, 2017-2032 (USD Million)
TABLE 359. BRICS Gene Editing Market Size, by CRISPR-Cas Nucleases, 2017-2032 (USD Million)
TABLE 360. BRICS Gene Editing Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 361. BRICS Gene Editing Market Size, by Target System, 2017-2032 (USD Million)
TABLE 362. BRICS Gene Editing Market Size, by Human Cells, 2017-2032 (USD Million)
TABLE 363. BRICS Gene Editing Market Size, by Non-Human Animal Systems, 2017-2032 (USD Million)
TABLE 364. BRICS Gene Editing Market Size, by Plant Systems, 2017-2032 (USD Million)
TABLE 365. BRICS Gene Editing Market Size, by Microbial Systems, 2017-2032 (USD Million)
TABLE 366. BRICS Gene Editing Market Size, by Editing Environment, 2017-2032 (USD Million)
TABLE 367. BRICS Gene Editing Market Size, by Application, 2017-2032 (USD Million)
TABLE 368. BRICS Gene Editing Market Size, by End User, 2017-2032 (USD Million)
TABLE 369. ASEAN Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 370. ASEAN Gene Editing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 371. ASEAN Gene Editing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 372. ASEAN Gene Editing Market Size, by Instruments & Devices, 2017-2032 (USD Million)
TABLE 373. ASEAN Gene Editing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 374. ASEAN Gene Editing Market Size, by Services, 2017-2032 (USD Million)
TABLE 375. ASEAN Gene Editing Market Size, by Technolo

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Revvity, Inc.
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Vertex Pharmaceuticals Incorporated
  • QIAGEN N.V.
  • CRISPR Therapeutics AG
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Synthego Corporation
  • Charles River Laboratories International, Inc.
  • VectorBuilder Inc.
  • Intellia Therapeutics, Inc.
  • Beam Therapeutics Inc.
  • Prime Medicine, Inc.
  • Editas Medicine, Inc.
  • Cellectis S.A.
  • Caribou Biosciences, Inc.
  • Precision BioSciences, Inc.
  • Mammoth Biosciences, Inc.
  • Arbor Biotechnologies, Inc.
  • Tessera Therapeutics, Inc.
  • Metagenomi Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Allogene Therapeutics, Inc.
  • Sana Biotechnology, Inc.
  • eGenesis, Inc.
  • Locus Biosciences, Inc.
  • Eligo Bioscience SA
  • HuidaGene Therapeutics Co., Ltd.
  • Ascidian Therapeutics, Inc.
  • Profluent Bio, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Bayer AG
  • Inari Agriculture, Inc.

Related Topics

Related Reports

Gene-Editing in Crops Market - Global Forecast 2026-2032 - Product Image

Gene-Editing in Crops Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Gene Editing Technology Innovation Platform Market - Global Forecast 2026-2032 - Product Image

Gene Editing Technology Innovation Platform Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Gene Editing - Global Strategic Business Report - Product Image

Gene Editing - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
CRISPR-based Gene Editing - Global Strategic Business Report - Product Image

CRISPR-based Gene Editing - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Gene Editing Market Size, Share & Trends Analysis Report by Product & Service, Technology, End-user, Region, and Segment Forecasts, 2026-2033 - Product Image

Gene Editing Market Size, Share & Trends Analysis Report by Product & Service, Technology, End-user, Region, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.